{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:10:28Z","timestamp":1787656228265,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.beem.2025.102018","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:14:32Z","timestamp":1749654872000},"page":"102018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The management of hypothalamic obesity in craniopharyngioma"],"prefix":"10.1016","volume":"39","author":[{"given":"Paul","family":"Dimitri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2025.102018_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ar.1090780203","article-title":"Hypothalamic lesions and adiposity in the rat","volume":"78","author":"Hetherington","year":"1940","journal-title":"Anat Rec"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3181\/00379727-77-18766","article-title":"Localization of a \"feeding center\" in the hypothalamus of the rat","volume":"77","author":"Anand","year":"1951","journal-title":"Proc Soc Exp Biol Med"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib3","first-page":"1276","article-title":"The hypothalamus and obesity","volume":"59","author":"Kennedy","year":"1966","journal-title":"Proc R Soc Med"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/beem.2002.0230","article-title":"Hypothalamic regulation of energy homeostasis","volume":"16","author":"Sainsbury","year":"2002","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrn3745","article-title":"Neurobiology of food intake in health and disease","volume":"15","author":"Morton","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"7424","key":"10.1016\/j.beem.2025.102018_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature11705","article-title":"Central nervous system control of metabolism","volume":"491","author":"Myers","year":"2012","journal-title":"Nature"},{"issue":"5738","key":"10.1016\/j.beem.2025.102018_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/282503a0","article-title":"Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons","volume":"282","author":"Woods","year":"1979","journal-title":"Nature"},{"issue":"5487","key":"10.1016\/j.beem.2025.102018_bib8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Br\u00fcning","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2013.06.014","article-title":"Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons","volume":"18","author":"Shi","year":"2013","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.beem.2025.102018_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105080","article-title":"Glucose rapidly induces different forms of excitatory synaptic plasticity in hypothalamic POMC neurons","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.beem.2025.102018_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1159\/000530804","article-title":"Alpha-melanocyte-stimulating hormone-mediated appetite regulation in the central nervous system","volume":"113","author":"Wu","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib12","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","article-title":"POMC: the physiological power of hormone processing","volume":"98","author":"Harno","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.beem.2025.102018_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnsys.2015.00150","article-title":"Hypothalamic control of brown adipose tissue thermogenesis","volume":"9","author":"Labb\u00e9","year":"2015","journal-title":"Front Syst Neurosci"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib14","doi-asserted-by":"crossref","first-page":"H433","DOI":"10.1152\/ajpheart.00176.2016","article-title":"Stimulation of the hypothalamic arcuate nucleus increases brown adipose tissue nerve activity via hypothalamic paraventricular and dorsomedial nuclei","volume":"311","author":"Chitravanshi","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00109-010-0651-0","article-title":"Alpha-melanocyte stimulating hormone: production and degradation","volume":"88","author":"D'Agostino","year":"2010","journal-title":"J Mol Med"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.4","article-title":"Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism","volume":"48","author":"Roh","year":"2016","journal-title":"Exp Mol Med"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib17","doi-asserted-by":"crossref","first-page":"R938","DOI":"10.1152\/ajpregu.00045.2016","article-title":"Role of leptin in energy expenditure: the hypothalamic perspective","volume":"312","author":"Pandit","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.beem.2025.102018_bib18","first-page":"102","article-title":"\u03b2-adrenoceptor signaling networks in adipocytes for recruiting stored fat and energy expenditure","volume":"2","author":"Collins","year":"2012","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib19","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/00006676-200408000-00019","article-title":"Relationships between the autonomic nervous system and the pancreas including regulation of regeneration and apoptosis: recent developments","volume":"29","author":"Kiba","year":"2004","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1172\/JCI59816","article-title":"Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice","volume":"122","author":"Berglund","year":"2012","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib21","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1172\/JCI43703","article-title":"Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice","volume":"121","author":"Scott","year":"2011","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib22","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1172\/JCI70338","article-title":"Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis","volume":"123","author":"Berglund","year":"2013","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.beem.2025.102018_bib23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/10.14.1465","article-title":"Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus","volume":"10","author":"Michaud","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40618-021-01737-8","article-title":"Serum alpha-melanocyte-stimulating hormone (a-MSH), brain-derived neurotrophic factor (BDNF), and agouti-related protein (AGRP) levels in children with Prader-Willi or Bardet-Biedl syndromes","volume":"45","author":"Turkkahraman","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib25","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102018_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108082","article-title":"Oxytocin in the neural control of eating: at the crossroad between homeostatic and non-homeostatic signals","volume":"171","author":"Romano","year":"2020","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.beem.2025.102018_bib27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn3044","article-title":"Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine","volume":"12","author":"Meyer-Lindenberg","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"23","key":"10.1016\/j.beem.2025.102018_bib28","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.febslet.2014.10.010","article-title":"Oxytocinergic circuit from paraventricular and supraoptic nuclei to arcuate POMC neurons in hypothalamus","volume":"588","author":"Maejima","year":"2014","journal-title":"FEBS Lett"},{"issue":"14","key":"10.1016\/j.beem.2025.102018_bib29","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.3390\/ijms22147737","article-title":"The effects of oxytocin on appetite regulation, food intake and metabolism in humans","volume":"22","author":"Kerem","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2017.09.043","article-title":"Dynamics of gut-brain communication underlying hunger","volume":"96","author":"Beutler","year":"2017","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2015.01.033","article-title":"Sensory detection of food rapidly modulates arcuate feeding circuits","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000054491","article-title":"Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat","volume":"70","author":"Willesen","year":"1999","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmet.2013.01.002","article-title":"Ghrelin regulates hypothalamic prolyl carboxypeptidase expression in mice","volume":"2","author":"Kwon Jeong","year":"2013","journal-title":"Mol Metab"},{"issue":"7702","key":"10.1016\/j.beem.2025.102018_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-018-0049-7","article-title":"Genetic identification of leptin neural circuits in energy and glucose homeostases","volume":"556","author":"Xu","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.peptides.2006.08.036","article-title":"NPY\/AgRP neurons are not essential for feeding responses to glucoprivation","volume":"28","author":"Luquet","year":"2007","journal-title":"Peptides"},{"issue":"5335","key":"10.1016\/j.beem.2025.102018_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4274\/jcrpe.2136","article-title":"Alpha-melanocyte-stimulating hormone and agouti-related protein: do they play a role in appetite regulation in childhood obesity?","volume":"8","author":"Vehapo\u011flu","year":"2016","journal-title":"J Clin Res Pedia Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.cell.2011.07.039","article-title":"Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop","volume":"146","author":"Yang","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2012.09.020","article-title":"GABAergic RIP-Cre neurons in the arcuate nucleus selectively regulate energy expenditure","volume":"151","author":"Kong","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.beem.2025.102018_bib40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neuron.2023.02.025","article-title":"An iterative neural processing sequence orchestrates feeding","volume":"111","author":"Liu","year":"2023","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.beem.2025.102018_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112789","article-title":"AgRP neurons are not indispensable for body weight maintenance in adult mice","volume":"42","author":"Cai","year":"2023","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2013.01.006","article-title":"Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN","volume":"17","author":"Shi","year":"2013","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cmet.2014.07.022","article-title":"The thermogenic effect of leptin is dependent on a distinct population of prolactin-releasing peptide neurons in the dorsomedial hypothalamus","volume":"20","author":"Dodd","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.beem.2025.102018_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnana.2015.00040","article-title":"Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons","volume":"9","author":"Wang","year":"2015","journal-title":"Front Neuroanat"},{"issue":"8","key":"10.1016\/j.beem.2025.102018_bib45","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1073\/pnas.1815744116","article-title":"TrkB-expressing neurons in the dorsomedial hypothalamus are necessary and sufficient to suppress homeostatic feeding","volume":"116","author":"Liao","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2025.102018_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10989-022-10391-4","article-title":"Role of lateral hypothalamus area in the central regulation of feeding","volume":"28","author":"Yousefvand","year":"2022","journal-title":"Int J Pept Res Ther"},{"issue":"11","key":"10.1016\/j.beem.2025.102018_bib47","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1210\/en.2018-00449","article-title":"Modulation of feeding and associated behaviors by lateral hypothalamic circuits","volume":"159","author":"Qualls-Creekmore","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2025.102018_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.114836","article-title":"Tachykinin-1-expressing parasubthalamic nucleus neurons are necessary for odorant-induced appetite suppression","volume":"292","author":"Kaegi","year":"2025","journal-title":"Physiol Behav"},{"key":"10.1016\/j.beem.2025.102018_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111250","article-title":"Jet al. The parasubthalamic nucleus: a novel eating center in the brain","volume":"136","author":"Lu","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.beem.2025.102018_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75470","article-title":"A discrete parasubthalamic nucleus subpopulation plays a critical role in appetite suppression","volume":"11","author":"Kim","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.beem.2025.102018_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170555","article-title":"Arginine vasopressin: direct and indirect action on metabolism","volume":"142","author":"Yoshimura","year":"2021","journal-title":"Peptides"},{"issue":"1-3","key":"10.1016\/j.beem.2025.102018_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2009.09.017","article-title":"Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor","volume":"622","author":"Aoyagi","year":"2009","journal-title":"Eur J Pharm"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/eat.20049","article-title":"Association between a vasopressin receptor AVPR1A promoter region microsatellite and eating behavior measured by a self-report questionnaire (Eating Attitudes Test) in a family-based study of a nonclinical population","volume":"36","author":"Bachner-Melman","year":"2004","journal-title":"Int J Eat Disord"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"M\u00fcller","year":"2001","journal-title":"Klin Padiatr"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3171\/jns.1992.76.1.0047","article-title":"Aggressive surgical management of craniopharyngiomas in children","volume":"76","author":"Hoffman","year":"1992","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/JPEM.2006.19.2.121","article-title":"Weight gain in craniopharyngioma--a model for hypothalamic obesity","volume":"19","author":"Ahmet","year":"2006","journal-title":"J Pedia Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib57","first-page":"193","article-title":"Childhood craniopharyngioma","volume":"69","author":"Muller","year":"2008","journal-title":"Recent Adv Diagn Treat Follow Horm Res"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-11-0158","article-title":"Study Committee of KRANIOPHARYNGEOM 2000. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up","volume":"165","author":"M\u00fcller","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.102018_bib59","article-title":"Risk factors for hypothalamic obesity in patients with adult-onset craniopharyngioma: a consecutive series of 120 cases","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib60","article-title":"The development of hypothalamic obesity in craniopharyngioma patients: a risk factor analysis in a well-defined cohort","volume":"65","author":"van Iersel","year":"2018","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1380089","article-title":"Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite","volume":"138","author":"Roth","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib62","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1203\/pdr.0b013e3180332cd6","article-title":"Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma","volume":"61","author":"Roth","year":"2007","journal-title":"Pedia Res"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib63","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1210\/jc.2003-030552","article-title":"Defect in epinephrine production in children with craniopharyngioma: functional or organic origin?","volume":"88","author":"Coutant","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2265.2009.03639.x","article-title":"Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma","volume":"72","author":"Simoneau-Roy","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"8-9","key":"10.1016\/j.beem.2025.102018_bib65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00381-005-1186-5","article-title":"Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome","volume":"21","author":"Caldarelli","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1469-8749.2004.tb00476.x","article-title":"Outcome of craniopharyngioma in children: long-term complications and quality of life","volume":"46","author":"Poretti","year":"2004","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"10.1016\/j.beem.2025.102018_bib67","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1007\/s00415-021-10794-1","article-title":"Sleep disturbances in craniopharyngioma: a challenging diagnosis","volume":"268","author":"Cordani","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.beem.2025.102018_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/519607","article-title":"Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives","volume":"2010","author":"M\u00fcller","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2025.102018_bib69","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","article-title":"Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients","volume":"87","author":"M\u00fcller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib70","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/oby.23616","article-title":"Effects of acute sleep loss on leptin, ghrelin, and adiponectin in adults with healthy weight and obesity: a laboratory study","volume":"31","author":"van Egmond","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/j.beem.2025.102018_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110007","article-title":"Circadian influences on feeding behavior","volume":"256","author":"la Fleur","year":"2024","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.beem.2025.102018_bib72","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/ijms20071597","article-title":"Off the clock: from circadian disruption to metabolic disease","volume":"20","author":"Maury","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib73","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/jc.2009-2003","article-title":"Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls","volume":"95","author":"O'Gorman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib74","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1210\/jc.2009-1412","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jc.2002-020511","article-title":"11 beta-Hydroxysteroid dehydrogenase activity in hypothalamic obesity","volume":"88","author":"Tiosano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib76","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1210\/jc.2016-2126","article-title":"Diazoxide in children with obesity after hypothalamic-pituitary lesions: a randomized, placebo-controlled trial","volume":"101","author":"Brauner","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib77","article-title":"Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int J Pedia Endocrinol"},{"issue":"1-2","key":"10.1016\/j.beem.2025.102018_bib78","first-page":"45","article-title":"Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience","volume":"28","author":"Kalina","year":"2015","journal-title":"J Pedia Endocrinol Metab"},{"issue":"2 Pt 1","key":"10.1016\/j.beem.2025.102018_bib79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3476(99)70017-X","article-title":"Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist","volume":"135","author":"Lustig","year":"1999","journal-title":"J Pedia"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib80","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.2002-030003","article-title":"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102018_bib81","unstructured":"Craig E. Supplemental NDA 21-008\/S-018. Clinical Review. Available at: \u3008https:\/\/www.fda.gov\/media\/115272\/download\u3009."},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP.14.6.697","article-title":"Treatment of hypothalamic obesity with caffeine and ephedrine","volume":"14","author":"Greenway","year":"2008","journal-title":"Endocr Pr"},{"issue":"11","key":"10.1016\/j.beem.2025.102018_bib83","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/meta.2002.35591","article-title":"Triiodothyronine supplementation for hypothalamic obesity","volume":"51","author":"Fernandes","year":"2002","journal-title":"Metabolism"},{"issue":"1-2","key":"10.1016\/j.beem.2025.102018_bib84","first-page":"53","article-title":"Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity","volume":"28","author":"van Santen","year":"2015","journal-title":"J Pedia Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib85","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2176\/nmc.41.210","article-title":"Mazindol administration improved hyperphagia after surgery for craniopharyngioma--case report","volume":"41","author":"Sadatomo","year":"2001","journal-title":"Neurol Med Chir"},{"key":"10.1016\/j.beem.2025.102018_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2011.00078","article-title":"Effects of methylphenidate on weight gain and food intake in hypothalamic obesity","volume":"2","author":"Elfers","year":"2011","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2025.102018_bib87","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharm Toxicol"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","article-title":"Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats","volume":"38","author":"Rowley","year":"2000","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/JPEM.2006.19.2.129","article-title":"Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury","volume":"19","author":"Ismail","year":"2006","journal-title":"J Pedia Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495851","article-title":"Treatment of hypothalamic obesity with dextroamphetamine: a case series","volume":"12","author":"Denzer","year":"2019","journal-title":"Obes Facts"},{"issue":"9","key":"10.1016\/j.beem.2025.102018_bib91","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archpedi.156.9.887","article-title":"The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma","volume":"156","author":"Mason","year":"2002","journal-title":"Arch Pedia Adolesc Med"},{"issue":"11","key":"10.1016\/j.beem.2025.102018_bib92","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1210\/jc.2007-0826","article-title":"Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes","volume":"92","author":"Danielsson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib93","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.beem.2025.102018_bib94","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dom.12928","article-title":"A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity","volume":"19","author":"Shoemaker","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.102018_bib95","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae200","article-title":"Treatment of hypothalamic obesity with GLP-1 analogs","volume":"9","author":"Dimitri","year":"2024","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib96","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.beem.2025.102018_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170342","article-title":"Intestinal glucagon-like peptide-1 effects on food intake: physiological relevance and emerging mechanisms","volume":"131","author":"Krieger","year":"2020","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.beem.2025.102018_bib98","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2025.102018_bib99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmet.2019.07.008","article-title":"Direct and indirect effects of liraglutide on hypothalamic POMC and NPY\/AgRP neurons - Implications for energy balance and glucose control","volume":"28","author":"He","year":"2019","journal-title":"Mol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.102018_bib100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMoa1903822","article-title":"Liraglutide in children and adolescents with type 2 diabetes","volume":"381","author":"Tamborlane","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib101","doi-asserted-by":"crossref","DOI":"10.2217\/cer-2022-0187","article-title":"STEP TEENS Investigators. Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study","volume":"12","author":"Weghuber","year":"2023","journal-title":"J Comp Eff Res"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/dom.14224","article-title":"A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity","volume":"23","author":"Roth","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.102018_bib103","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/dom.14366","article-title":"MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesity","volume":"23","author":"Perez","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib104","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ejendo\/lvae024","article-title":"Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial","volume":"190","author":"Gatta-Cherifi","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2025.102018_bib105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa2302392","article-title":"Daily oral GLP-1 receptor agonist orforglipron for adults with obesity","volume":"389","author":"Wharton","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist","volume":"375","author":"K\u00fchnen","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.beem.2025.102018_bib107","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Cl\u00e9ment","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.beem.2025.102018_bib109","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molmet.2016.07.009","article-title":"\u03b1-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors","volume":"5","author":"Enriori","year":"2016","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.102018_bib110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2011.01.010","article-title":"Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis","volume":"13","author":"Rossi","year":"2011","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib111","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.beem.2025.102018_bib112","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","article-title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","volume":"10","author":"Haqq","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib113","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","article-title":"Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial","volume":"12","author":"Roth","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2025.102018_bib114","unstructured":"\u3008https:\/\/ir.rhythmtx.com\/news-releases\/news-release-details\/rhythm-pharmaceuticals-announces-pivotal-phase-3-transcend-trial\u3009."},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.15252\/emmm.201404508","article-title":"Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice","volume":"7","author":"Clemmensen","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.beem.2025.102018_bib116","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-21-0972","article-title":"Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity","volume":"186","author":"Huynh","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"10.1016\/j.beem.2025.102018_bib117","doi-asserted-by":"crossref","first-page":"10859","DOI":"10.3390\/ijms221910859","article-title":"Oxytocin and food intake control: neural, behavioral, and signaling mechanisms","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2025.102018_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108082","article-title":"Oxytocin in the neural control of eating: at the crossroad between homeostatic and non-homeostatic signals","volume":"171","author":"Romano","year":"2020","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.beem.2025.102018_bib119","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","article-title":"Intranasal carbetocin reduces hyperphagia, anxiousness, and distress in prader-willi syndrome: CARE-PWS phase 3 trial","volume":"108","author":"Roof","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib120","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cen.14387","article-title":"Oxytocin in young children with Prader-Willi syndrome: results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin","volume":"94","author":"Damen","year":"2021","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib121","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad037","article-title":"A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in individuals with hypothalamic obesity","volume":"7","author":"McCormack","year":"2023","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib122","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1152\/ajpendo.00418.2016","article-title":"CNS \u03b23-adrenergic receptor activation regulates feeding behavior, white fat browning, and body weight","volume":"313","author":"Richard","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.102018_bib123","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI134892","article-title":"The \u03b23-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans","volume":"130","author":"Finlin","year":"2020","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.beem.2025.102018_bib124","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int J Obes"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2500051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2500051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:35:43Z","timestamp":1760542543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X2500051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":124,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1521690X2500051X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.102018","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The management of hypothalamic obesity in craniopharyngioma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.102018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102018"}}